REG - Oncimmune Hldngs PLC - Director/PDMR's Dealing

Oncimmune HoldingsAnnouncement

05/06/2020 07:00

RNS Number : 0419P
  
Oncimmune Holdings PLC
  
05 June 2020
  
 

Oncimmune Holdings plc
 
("Oncimmune" or the "Company")
 
Director/PDMR's Dealing
 
Oncimmune Holdings plc (AIM: ONC.L), the leading global immunodiagnostics group, was informed that, on 4 June 2020, dealings in the Company's ordinary shares of £0.01 each in the Company ("Ordinary Shares") by the following Director / PDMRs had occurred: 
 
-       Meinhard Schmidt, Non-Executive Chairman, together with his wife and PCA, Tatiana Schmidt, acquired in aggregate 13,000 Ordinary Shares at a weighted average price of £1.885 per share
 
-       Tim Bunting, Non-Executive Director, acquired 150,000 Ordinary Shares at a weighted average price of £1.192 per share
 
-       Adam Hill, Chief Executive Officer, acquired 8,481 Ordinary Shares at a price of £1.179 per share
 
-       Matthew Hall, Chief Financial Officer, acquired 1,272 Ordinary Shares at a price of £1.179 per share
 
-       Ron Kirschner, General Counsel and Company Secretary, acquired 1,652 Ordinary Shares at a price of £1.204 per share
 
 



Director/PDMR/ PCA


No. of Ordinary Shares acquired


Resulting interest


Resulting % holding




Meinhard Schmidt / Tatiana Schmidt


13,000


31,000


0.05%




Tim Bunting


150,000


2,956,717


4.7%




Adam Hill


8,481


40,913


0.06%




Matthew Hall


1,272


11,935


0.02%




Ron Kirschner


1,652


1,652


0.003%



 
This announcement, including the notification below, is made in accordance with the requirements of Article 19 of the EU Market Abuse Regulation.
 
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.
 
 



1
 


Details of the person discharging managerial responsibilities / person closely associated
 




a)
 


Name


Meinhard Schmidt / Tatiana Schmidt




2
 


Reason for the notification




a)
 


Position/status
 


Non-executive Chairman / PCA




b)
 


Initial notification /Amendment


Initial notification




3
 


Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
 




a)
 


Name
 


Oncimmune Holdings plc




b)
 


LEI


213800HCYIWT6YPI1I02 




4
 


Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted




a)
 


Description of the financial instrument, type of instrument


Ordinary Shares of £0.01 each
 














Identification code


ISIN: GB00BYQ94H38














b)
 


Nature of the transaction


Purchase of shares




c)
 


Price(s) and volume(s)




























Price


Volume
















£1.17


8,000
















£1.21


5,000






























d)
 


Aggregated information


















- Aggregated volume


13,000 shares
Weighted average price of £1.885














- Price


















e)
 


Date of the transaction 


4 June 2020




f)
 


Place of the transaction


London stock exchange, AIM



 
 



1
 


Details of the person discharging managerial responsibilities / person closely associated
 




a)
 


Name


Timothy Bunting




2
 


Reason for the notification
 




a)
 


Position/status
 


Non-executive Director




b)
 


Initial notification /Amendment


Initial notification




3
 


Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor




a)
 


Name
 


Oncimmune Holdings plc




b)
 


LEI


213800HCYIWT6YPI1I02 




4
 


Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted




a)
 


Description of the financial instrument, type of instrument


Ordinary Shares of £0.01 each
 














Identification code


ISIN: GB00BYQ94H38














b)
 


Nature of the transaction
 


Purchase of shares




c)
 


Price(s) and volume(s)




























Price


Volume
















£1.195


60,000
















£1.19


90,000






























d)
 


Aggregated information


















- Aggregated volume


150,000 shares
Weighted average price of £1.192














- Price


















e)
 


Date of the transaction 


4 June 2020




f)
 


Place of the transaction


London stock exchange, AIM



 
 



1
 


Details of the person discharging managerial responsibilities / person closely associated
 




a)
 


Name


Dr Adam Mark Hill




2
 


Reason for the notification
 




a)
 


Position/status
 


Chief Executive Officer




b)
 


Initial notification /Amendment


Initial notification




3
 


Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
 




a)
 


Name
 


Oncimmune Holdings plc




b)
 


LEI


213800HCYIWT6YPI1I02 




4
 


Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
 
 




a)
 


Description of the financial instrument, type of instrument


Ordinary Shares of £0.01 each
 














Identification code


ISIN: GB00BYQ94H38














b)
 


Nature of the transaction
 


Purchase of shares




c)
 


Price(s) and volume(s)




























Price


Volume
















£1.179


8,481






























d)
 


Aggregated information


















- Aggregated volume


Same as above














- Price


















e)
 


Date of the transaction 


4 June 2020




f)
 


Place of the transaction
 


London stock exchange, AIM



 
 



1
 


Details of the person discharging managerial responsibilities / person closely associated
 




a)
 


Name


Matthew Hall




2
 


Reason for the notification
 




a)
 


Position/status
 


Chief Financial Officer




b)
 


Initial notification /Amendment


Initial notification




3
 


Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
 




a)
 


Name
 


Oncimmune Holdings plc




b)
 


LEI


213800HCYIWT6YPI1I02 




4
 


Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted




a)
 


Description of the financial instrument, type of instrument


Ordinary Shares of £0.01 each
 














Identification code


ISIN: GB00BYQ94H38














b)
 


Nature of the transaction


Purchase of shares




c)
 


Price(s) and volume(s)




























Price


Volume
















£117.9


1,272






























d)
 


Aggregated information


















- Aggregated volume


Same as above














- Price


















e)
 


Date of the transaction 


4 June 2020




f)
 


Place of the transaction


London stock exchange, AIM



 
 



1
 


Details of the person discharging managerial responsibilities / person closely associated
 




a)
 


Name


Ron Kirschner




2
 


Reason for the notification
 




a)
 


Position/status


General Counsel and Company Secretary




b)
 


Initial notification /Amendment


Initial notification




3
 


Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor




a)
 


Name


Oncimmune Holdings plc




b)
 


LEI


213800HCYIWT6YPI1I02 




4
 


Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted




a)
 


Description of the financial instrument, type of instrument


Ordinary Shares of £0.01 each
 














Identification code


ISIN: GB00BYQ94H38














b)
 


Nature of the transaction


Purchase of shares




c)
 


Price(s) and volume(s)




























Price


Volume
















£1.204


1,652






























d)
 


Aggregated information


















- Aggregated volume


Same as above














- Price


















e)
 


Date of the transaction 


4 June 2020




f)
 


Place of the transaction


London stock exchange, AIM



 
 
For further information:
 
Oncimmune Holdings plc
Ron Kirschner, General Counsel and Company Secretary
contact@oncimmune.com
 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
  END
 
 
DSHSSWESLESSEFM